Podcasts Science Journal of Clinical Oncology (JCO) Podcast Should Myeloma Residual Disease Become a Standard Assay for Large Cooperative Groups and Myeloma Referral Centers?

Should Myeloma Residual Disease Become a Standard Assay for Large Cooperative Groups and Myeloma Referral Centers?

Published: June 3, 2013, 9:05 p.m.

Minimal residual disease predicts outcomes in myeloma.